Alcon Inc. (SWX:ALC)
59.84
-0.90 (-1.48%)
Sep 24, 2025, 11:45 AM CET
Alcon Revenue
Alcon had revenue of $2.60B USD in the quarter ending June 30, 2025, with 4.01% growth. This brings the company's revenue in the last twelve months to $10.03B, up 4.04% year-over-year. In the year 2024, Alcon had annual revenue of $9.91B with 4.82% growth.
Revenue (ttm)
$10.03B
Revenue Growth
+4.04%
P/S Ratio
3.77
Revenue / Employee
$391.62K
Employees
25,599
Market Cap
30.03B CHF
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.91B | 456.00M | 4.82% |
Dec 31, 2023 | 9.46B | 738.00M | 8.47% |
Dec 31, 2022 | 8.72B | 426.00M | 5.14% |
Dec 31, 2021 | 8.29B | 1.46B | 21.34% |
Dec 31, 2020 | 6.83B | -675.00M | -8.99% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 63.49B |
Novartis AG | 43.89B |
Lonza Group AG | 7.09B |
Galderma Group AG | 3.73B |
Sandoz Group AG | 8.42B |
Straumann Holding AG | 2.58B |
Sonova Holding AG | 3.87B |
Ypsomed Holding AG | 748.87M |
Alcon News
- 1 day ago - Merger Agreement Advances as Alcon (ALC) Clears 'Window Shop' Period - GuruFocus
- 1 day ago - Yunqi Capital Opposes Staar Surgical (STAA) Sale to Alcon - GuruFocus
- 1 day ago - Yunqi Capital Rejects Alcon's Acquisition Proposal of STAAR Surgical (ALC) - GuruFocus
- 1 day ago - STAAR Surgical Announces Expiration of “Window Shop” Period; No Competing Acquisition Proposals Received - Business Wire
- 2 days ago - Major shareholder Yunqi Capital to vote against Staar Surgical 's proposed sale to Alcon - Seeking Alpha
- 2 days ago - Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company's Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon - Business Wire
- 4 days ago - Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now? - Nasdaq
- 5 days ago - Alcon's UNITY VCS Shows Superior Efficiency in Studies, Stock Up - Nasdaq